X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-12 | CELU | Lim Kok Thay | 10% | P - Purchase | $0.25 | +21,410,983 | 51,509,907 | +71% | +$5,331,335 | |||||
| M | 2023-09-29 | CELU | Hariri Robert J | CEO | P - Purchase | $0.16 | +18,422,124 | 28,570,434 | +182% | +$2,984,294 | |||||
| M | 2023-09-29 | CELU | Sorrento Therapeutics, Inc. | 10% | S - Sale | $0.00 | -15,371,697 | 5,050,427 | -75% | -$0 | |||||
2022-11-30 | CELU | Hariri Robert J | CEO | P - Purchase | $1.72 | +10,000 | 8,074,996 | 0% | +$17,175 | ||||||
2022-11-29 | CELU | Hariri Robert J | CEO | P - Purchase | $1.71 | +40,000 | 8,064,996 | 0% | +$68,400 | ||||||
2022-11-28 | CELU | Hariri Robert J | CEO | P - Purchase | $1.74 | +40,000 | 8,024,996 | +1% | +$69,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |